×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ACET – adicet bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ACET
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
11:46 am
acet
Adicet Bio, Inc. (NASDAQ: ACET) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Medium
Report
Adicet Bio, Inc. (NASDAQ: ACET) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
12/19
07:13 am
acet
Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma [Yahoo! Finance]
Medium
Report
Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma [Yahoo! Finance]
12/19
07:00 am
acet
Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
Medium
Report
Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
12/18
07:19 am
acet
Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer [Yahoo! Finance]
Medium
Report
Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer [Yahoo! Finance]
12/18
07:00 am
acet
Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer
Medium
Report
Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer
11/29
04:44 pm
acet
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
11/20
12:04 am
acet
Adicet Bio, Inc. (NASDAQ: ACET) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Adicet Bio, Inc. (NASDAQ: ACET) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/18
04:00 pm
acet
Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
Medium
Report
Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/19
04:01 pm
acet
Form 8-K Adicet Bio, Inc. For: Dec 19
Medium
Report
Form 8-K Adicet Bio, Inc. For: Dec 19
11/27
05:12 pm
acet
Form 8-K Adicet Bio, Inc. For: Nov 27
Medium
Report
Form 8-K Adicet Bio, Inc. For: Nov 27
11/18
04:02 pm
acet
Form 8-K Adicet Bio, Inc. For: Nov 18
Medium
Report
Form 8-K Adicet Bio, Inc. For: Nov 18
11/15
04:04 pm
acet
Form 8-K Adicet Bio, Inc. For: Nov 08
Low
Report
Form 8-K Adicet Bio, Inc. For: Nov 08
11/14
05:46 pm
acet
Form SC 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
High
Report
Form SC 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
11/14
04:06 pm
acet
Form SC 13G/A Adicet Bio, Inc. Filed by: COMMODORE CAPITAL LP
High
Report
Form SC 13G/A Adicet Bio, Inc. Filed by: COMMODORE CAPITAL LP
11/14
04:00 pm
acet
Form SC 13G/A Adicet Bio, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
High
Report
Form SC 13G/A Adicet Bio, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
11/14
06:08 am
acet
Form SC 13G/A Adicet Bio, Inc. Filed by: RTW INVESTMENTS, LP
High
Report
Form SC 13G/A Adicet Bio, Inc. Filed by: RTW INVESTMENTS, LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: